ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Abstract 1770: Morab-202, a folate receptor alpha-targeted antibody-drug conjugate, shows a highly potent activity against a panel of FRA-expressing tumors
Mapping Intimacies
◽
10.1158/1538-7445.am2018-1770
◽
2018
◽
Author(s):
Caroline Mignard
◽
Coralie DURIX
◽
Katherine Rybinski
◽
Xin Cheng
◽
Keiji Furuuchi
◽
...
Keyword(s):
Folate Receptor
◽
Antibody Drug Conjugate
◽
Folate Receptor Alpha
◽
Receptor Alpha
◽
Drug Conjugate
◽
Antibody Drug
Download Full-text
Related Documents
Cited By
References
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202, a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Case Medical Research
◽
10.31525/ct1-nct04300556
◽
2020
◽
Author(s):
Keyword(s):
Folate Receptor
◽
Antibody Drug Conjugate
◽
Folate Receptor Alpha
◽
Receptor Alpha
◽
Drug Conjugate
◽
Tumor Types
◽
Antibody Drug
Download Full-text
FORWARD I (GOG 3011): A phase III study of mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), versus chemotherapy in patients (pts) with platinum-resistant ovarian cancer (PROC)
Annals of Oncology
◽
10.1093/annonc/mdz250
◽
2019
◽
Vol 30
◽
pp. v403
◽
Cited By ~ 8
Author(s):
K. Moore
◽
A. Oza
◽
N. Colombo
◽
A. Oaknin
◽
G. Scambia
◽
...
Keyword(s):
Ovarian Cancer
◽
Folate Receptor
◽
Phase Iii
◽
Antibody Drug Conjugate
◽
Folate Receptor Alpha
◽
Receptor Alpha
◽
Drug Conjugate
◽
Platinum Resistant
◽
Phase Iii Study
◽
Antibody Drug
Download Full-text
Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models
Neoplasia
◽
10.1016/j.neo.2016.11.002
◽
2016
◽
Vol 18
(12)
◽
pp. 775-784
◽
Cited By ~ 29
Author(s):
Jose F. Ponte
◽
Olga Ab
◽
Leanne Lanieri
◽
Jenny Lee
◽
Jennifer Coccia
◽
...
Keyword(s):
Ovarian Cancer
◽
Folate Receptor
◽
Standard Of Care
◽
Antibody Drug Conjugate
◽
Folate Receptor Alpha
◽
Receptor Alpha
◽
Drug Conjugate
◽
Cancer Models
◽
Antibody Drug
Download Full-text
Safety Profile of Mirvetuximab Soravtansine, a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Patients with Recurrent Ovarian Cancer
Gynecologic Oncology
◽
10.1016/j.ygyno.2019.11.066
◽
2020
◽
Vol 156
(3)
◽
pp. e15-e16
Author(s):
Kathleen G. Essel
◽
Lainie P. Martin
◽
David M. O’Malley
◽
Ursula Matulonis
◽
Jason A. Konner
◽
...
Keyword(s):
Ovarian Cancer
◽
Safety Profile
◽
Folate Receptor
◽
Recurrent Ovarian Cancer
◽
Antibody Drug Conjugate
◽
Folate Receptor Alpha
◽
Receptor Alpha
◽
Drug Conjugate
◽
Antibody Drug
Download Full-text
Mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), in combination with carboplatin and bevacizumab: Initial results from a phase Ib study in patients (pts) with ovarian cancer
Annals of Oncology
◽
10.1093/annonc/mdz250.036
◽
2019
◽
Vol 30
◽
pp. v419-v420
Author(s):
D. O'Malley
◽
D. Richardson
◽
I.B. Vergote
◽
L. Gilbert
◽
L.P. Martin
◽
...
Keyword(s):
Ovarian Cancer
◽
Folate Receptor
◽
Antibody Drug Conjugate
◽
Folate Receptor Alpha
◽
Phase Ib
◽
Receptor Alpha
◽
Drug Conjugate
◽
Initial Results
◽
Antibody Drug
Download Full-text
Initial safety and activity findings from a phase IB escalation study of mirvetuximab soravtansine, a folate receptor alpha (FRα-targeting antibody-drug conjugate (ADC), with pembrolizumab in platinum-resistant epithelial ovarian cancer (EOC) patients
Gynecologic Oncology
◽
10.1016/j.ygyno.2018.04.085
◽
2018
◽
Vol 149
◽
pp. 38
◽
Cited By ~ 10
Author(s):
U.A. Matulonis
◽
K.N. Moore
◽
L.P. Martin
◽
I.B. Vergote
◽
C.M. Castro
◽
...
Keyword(s):
Ovarian Cancer
◽
Epithelial Ovarian Cancer
◽
Folate Receptor
◽
Antibody Drug Conjugate
◽
Folate Receptor Alpha
◽
Phase Ib
◽
Receptor Alpha
◽
Drug Conjugate
◽
Platinum Resistant
◽
Antibody Drug
Download Full-text
Combination Regimens of Mirvetuximab Soravtansine, A Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, With Standard-Of-Care Agents Offer Promise for the Treatment of Ovarian Cancer
Health Care Current Reviews
◽
10.4172/2375-4273.1000195
◽
2017
◽
Vol 05
(02)
◽
Author(s):
Todd M Bauer
Keyword(s):
Ovarian Cancer
◽
Folate Receptor
◽
Standard Of Care
◽
Antibody Drug Conjugate
◽
Folate Receptor Alpha
◽
Receptor Alpha
◽
Drug Conjugate
◽
Combination Regimens
◽
Antibody Drug
Download Full-text
Preclinical evaluation of M-DGN549, a folate receptor alpha-targeting antibody–drug conjugate (ADC) with a DNA-alkylating payload
European Journal of Cancer
◽
10.1016/s0959-8049(16)33030-1
◽
2016
◽
Vol 69
◽
pp. S145
Author(s):
Y. Setiady
◽
L. Lanieri
◽
O. Ab
◽
E. Maloney
◽
E. Hong
◽
...
Keyword(s):
Folate Receptor
◽
Antibody Drug Conjugate
◽
Folate Receptor Alpha
◽
Preclinical Evaluation
◽
Receptor Alpha
◽
Drug Conjugate
◽
Antibody Drug
Download Full-text
Safety and activity findings from a phase 1b escalation study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with carboplatin in patients with platinum-sensitive ovarian cancer
Gynecologic Oncology
◽
10.1016/j.ygyno.2018.07.017
◽
2018
◽
Vol 151
(1)
◽
pp. 46-52
◽
Cited By ~ 16
Author(s):
Kathleen N. Moore
◽
David M. O'Malley
◽
Ignace Vergote
◽
Lainie P. Martin
◽
Antonio Gonzalez-Martin
◽
...
Keyword(s):
Ovarian Cancer
◽
Folate Receptor
◽
Antibody Drug Conjugate
◽
Folate Receptor Alpha
◽
Receptor Alpha
◽
Drug Conjugate
◽
Platinum Sensitive
◽
Phase 1B
◽
Antibody Drug
Download Full-text
In Vitro and In Vivo Activity of IMGN853, an Antibody–Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers
Molecular Cancer Therapeutics
◽
10.1158/1535-7163.mct-17-0930
◽
2018
◽
Vol 17
(5)
◽
pp. 1003-1011
◽
Cited By ~ 10
Author(s):
Gary Altwerger
◽
Elena Bonazzoli
◽
Stefania Bellone
◽
Tomomi Egawa-Takata
◽
Gulden Menderes
◽
...
Keyword(s):
Folate Receptor
◽
Antibody Drug Conjugate
◽
Folate Receptor Alpha
◽
Receptor Alpha
◽
Drug Conjugate
◽
Endometrial Cancers
◽
Antibody Drug
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close